Verteporfin
Visudyne (verteporfin) is a small molecule pharmaceutical. Verteporfin was first approved as Visudyne on 2000-04-12. It is used to treat choroidal neovascularization in the USA. It has been approved in Europe to treat degenerative myopia and macular degeneration.
| Trade Name | Visudyne |
|---|---|
| Common Name | Verteporfin |
| Indication | choroidal neovascularization, degenerative myopia, macular degeneration |
| Drug Class | Benzoporphyrin derivatives |
